AWIR was formed to promote the science and practice of rheumatology, with a focus on the advancement and education of women in the field.
The giant cell arteritis treatment tocilizumab has been approved by the FDA.
Alendronate treatment was associated with a significantly lower risk for hip fracture among older patients.
In patients with osteoarthritis, corticosteroid injection was associated with significant hip pain reduction.
The efficacy of lower doses of MTX in patients with rheumatoid arthritis in combination with ADA was studied.
Patients receiving disease-modifying anti-rheumatic drugs (DMARDs) saw no positive dynamics of mental disorders.
Sirukumab, a human monoclonal antibody that selectively binds to the interleukin 6 cytokine with high affinity, can help reduce depressive symptoms in patients with rheumatoid arthritis.
When combined with ultrasound examination, ANG-2 can help lead to the appropriate therapy for JIA.